These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9800932)

  • 21. Time points and risk factors for RhD immunizations after the implementation of targeted routine antenatal anti-D prophylaxis: A retrospective nationwide cohort study.
    Jernman R; Isaksson C; Haimila K; Kuosmanen M; Mäkikallio-Anttila K; Toivonen S; Ordén MR; Sulin K; Tihtonen K; Vääräsmäki M; Sainio S
    Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1868-1875. PubMed ID: 34157128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do chorionic villus samplings (CVS) or amniocenteses (AC) induce RhD immunisation? An evaluation of a large Danish cohort with no routine administration of anti-D after invasive prenatal testing.
    Kristensen SS; Nørgaard LN; Tabor A; Sundberg K; Dziegiel MH; Hedegaard M; Ekelund CK
    BJOG; 2019 Nov; 126(12):1476-1480. PubMed ID: 31283084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: a scoping review.
    Fyfe TM; Ritchey MJ; Taruc C; Crompton D; Galliford B; Perrin R
    BMC Pregnancy Childbirth; 2014 Dec; 14():411. PubMed ID: 25491600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis.
    Neovius M; Tiblad E; Westgren M; Kublickas M; Neovius K; Wikman A
    BJOG; 2016 Jul; 123(8):1337-46. PubMed ID: 26663771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antenatal prophylaxis of Rh immunization with 250 micrograms anti-D immunoglobulin.
    Hermann M; Kjellman H; Ljunggren C
    Acta Obstet Gynecol Scand Suppl; 1984; 124():1-15. PubMed ID: 6095582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
    Howard HL; Martlew VJ; McFadyen IR; Clarke CA
    Br J Obstet Gynaecol; 1997 Jan; 104(1):37-41. PubMed ID: 8988694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme.
    Bolton-Maggs PH; Davies T; Poles D; Cohen H
    BJOG; 2013 Jun; 120(7):873-8. PubMed ID: 23489292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae.
    Tovey LA; Townley A; Stevenson BJ; Taverner J
    Lancet; 1983 Jul; 2(8344):244-6. PubMed ID: 6135077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of maternal sensitisation to Rh(D) in Christchurch, New Zealand and reasons for prophylaxis failures.
    Badami KG; Parker J; Kenny A; Warrington S
    N Z Med J; 2014 Jan; 127(1388):40-6. PubMed ID: 24481385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-D administration in pregnancy for preventing rhesus alloimmunisation.
    Crowther CA; Keirse MJ
    Cochrane Database Syst Rev; 2000; (2):CD000020. PubMed ID: 10796088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands.
    de Haas M; Thurik FF; van der Ploeg CP; Veldhuisen B; Hirschberg H; Soussan AA; Woortmeijer H; Abbink F; Page-Christiaens GC; Scheffer PG; Ellen van der Schoot C
    BMJ; 2016 Nov; 355():i5789. PubMed ID: 27821701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme.
    Mayne S; Parker JH; Harden TA; Dodds SD; Beale JA
    BMJ; 1997 Dec; 315(7122):1588. PubMed ID: 9437277
    [No Abstract]   [Full Text] [Related]  

  • 34. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.
    Okwundu CI; Afolabi BB
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women.
    Darlington M; Carbonne B; Mailloux A; Brossard Y; Levy-Mozziconacci A; Cortey A; Maoulida H; Simon T; Rousseau A; Durand-Zaleski I;
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):496. PubMed ID: 30547830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-D quantification in relation to anti-D titre, middle cerebral artery Doppler measurement and clinical outcome in RhD-immunized pregnancies.
    Wikman A; Jalkesten E; Ajne G; Höglund P; Mörtberg A; Tiblad E
    Vox Sang; 2018 Nov; 113(8):779-786. PubMed ID: 30311187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of 250 μg anti-D IgG in the third trimester of pregnancy: an observational study.
    Tiblad E; Wikman A; Rane A; Jansson Y; Westgren M
    Acta Obstet Gynecol Scand; 2012 May; 91(5):587-92. PubMed ID: 22352370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single dose v two-dose antenatal anti-D prophylaxis: a randomised controlled trial.
    White SW; Cheng JC; Penova-Veselinovic B; Wang C; White M; Ingleby B; Arnold C; Pennell CE
    Med J Aust; 2019 Sep; 211(6):261-265. PubMed ID: 31304600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of RhD alloimmunization in RhD negative women.
    Lubusky M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Mar; 154(1):3-7. PubMed ID: 20445704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.